Skip to main content

and
  1. No Access

    Article

    Establishment of an acquired lorlatinib-resistant cell line of non-small cell lung cancer and its mediated resistance mechanism

    Although lorlatinib, the third generation of echinoderm microtubule protein 4-anaplastic lymphoma kinase (EML4-ALK) tyrosine kinase inhibitor (TKI), overcame the previous generation ALK-TKIs’ drug resistance p...

    Bo **e, Ying Qiu, Juan Zhou, Dou Du, Haochuan Ma in Clinical and Translational Oncology (2022)